Global Diabetes Drugs and Diagnostics Market to Reach US$ 134.0 Billion by 2032, Stimulated by Increasing Prevalence of Diabetes

August 28, 2023 | Healthcare

According to the latest report by IMARC Group, titled “Diabetes Drugs and Diagnostics Market Report by Segment (Oral Antidiabetics, Insulin, Diabetes Diagnostics), and Region 2024-2032,” the global diabetes drugs and diagnostics market size reached US$ 74.0 Billion in 2023. Diabetes drugs and diagnostics refers to the expansive industry centered around medications and diagnostic tools designed to manage and diagnose diabetes. It encompasses a wide range of pharmaceutical products and diagnostic devices tailored to treat and monitor diabetes effectively. Diabetes drugs play a crucial role in controlling blood glucose levels, while diagnostic tools aid in early detection, ongoing monitoring, and accurate management of the disease. It offers innovative solutions that empower patients and healthcare professionals in their battle against diabetes, enhancing the quality of life for those affected and mitigating the potential complications associated with the condition.

Global Diabetes Drugs and Diagnostics Market Trends:

The growing prevalence of diabetes across the globe due to the increasing sedentary lifestyles, unhealthy dietary habits, and geriatric population is one of the major drivers contributing to the market growth. Additionally, the ongoing research and development (R&D) efforts by pharmaceutical companies and diagnostic device manufacturers, striving to innovate and introduce novel products that offer improved efficacy and convenience, are creating a positive outlook for the market. Moreover, the growing awareness among individuals and healthcare professionals regarding diabetes management and early detection is also contributing to the market growth. Furthermore, the increasing adoption of advanced technologies, such as continuous glucose monitoring systems and smartphone applications for diabetes management, that offer real-time data and enhanced patient convenience is providing a considerable boost to the market growth. In addition to this, the rising collaboration and partnerships between pharmaceutical companies, diagnostic device manufacturers, and healthcare institutions aimed at leveraging collective expertise and resources to develop comprehensive diabetes management solutions, are favoring the market growth. These collaborative efforts enhance product portfolios, foster technological advancements, and address unmet medical needs, ultimately benefiting patients. Additionally, the sudden shift toward patient-centric care and growing emphasis on preventive healthcare prompting governments and healthcare organizations to focus on diabetes prevention and management programs, such as early screening and timely intervention, is providing remunerative growth opportunities for the market. Looking forward, the market value is projected to reach US$ 134.0 Billion by 2032, expanding at a CAGR of 6.8% during 2024-2032.

Market Summary:

Based on the segment, the market has been categorized into oral antidiabetics (breakup by class- biguanides, alpha-glucosidase inhibitors, sodium-glucose cotransport -2 inhibitors (SGLT-2 inhibitors), dipeptidyl peptidase-4 inhibitors (DPP-4 inhibitors), sulfonylureas, dopamine -D2 receptor agonist and others, insulin (breakup by class- long-acting insulin, fast-acting insulin, short acting, and others), diabetes diagnostics (breakup by product type- blood glucose meters, blood glucose strips and lancets; breakup by end-user- hospitals and clinics, home healthcare, ambulatory care centers and others).
Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
The competitive landscape of the market has also been examined along with the profile of the key players.

Report Scope:

Report Features	Details
Base Year of the Analysis	2023
Historical Period	2018-2023
Forecast Period	2024-2032
Units	US$ Billion
Scope of the Report	Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment: Segment Region
Segments Covered	Oral Antidiabetics, Insulin, Diabetes Diagnostics
Region Covered	North America, Europe, Asia Pacific, Middle East and Africa, Latin America
Customization Scope	10% Free Customization
Report Price and Purchase Option	Single User License: US$ 3899 Five User License: US$ 4899 Corporate License: US$ 5899
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Global Diabetes Drugs and Diagnostics Market to Reach US$ 134.0 Billion by 2032, Stimulated by Increasing Prevalence of Diabetes

Purchase options

Single User License ~~$3899~~ $2999
Five User License ~~$4899~~ $3999
Corporate User License ~~$5899~~ $4999

Inquire Before Buying

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Speak to an Analyst

Request Brochure

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.